Literature DB >> 21771572

Macrophage infiltration predicts a poor prognosis for human ewing sarcoma.

Toshifumi Fujiwara1, Jun-ichi Fukushi, Shunsaku Yamamoto, Yoshihiro Matsumoto, Nokitaka Setsu, Yoshinao Oda, Hisakata Yamada, Seiji Okada, Kosuke Watari, Mayumi Ono, Michihiko Kuwano, Satoshi Kamura, Keiichiro Iida, Yuko Okada, Mihoko Koga, Yukihide Iwamoto.   

Abstract

Ewing sarcoma-primitive neuroectodermal tumor (EWS) is associated with the most unfavorable prognosis of all primary musculoskeletal tumors. The objective of the present study was to investigate whether tumor-associated macrophages (TAMs) affect the development of EWS. TAMs were isolated from mouse xenografts using CD11b magnetic beads and examined for their cytokine expression and osteoclastic differentiation. To evaluate the role of TAMs in xenograft formation, liposome-encapsulated clodronate was used to deplete TAMs in mice. Macrophage infiltration and tumor microvascular density were histologically evaluated in 41 patients with EWS, and association with prognosis was examined using Kaplan-Meier survival analysis. In mouse EWS xenografts, TAMs expressed higher concentrations of cytokines including interleukin-6, keratinocyte-derived chemokine, and monocyte chemotactic protein-1. TAMs were more capable than normal monocytes of differentiating into tartrate-resistant acid phosphatase-positive giant cells. Depleting macrophages using liposome-encapsulated clodronate significantly inhibited development of EWS xenografts. In human EWS samples, higher levels of CD68-positive macrophages were associated with poorer overall survival. In addition, enhanced vascularity, increase in the amount of C-reactive protein, and higher white blood cell counts were also associated with poor prognosis and macrophage infiltration. TAMs seem to enhance the progression of EWS by stimulating both angiogenesis and osteoclastogenesis. Further investigation of the behavior of TAMs may lead to development of biologically targeted therapies for EWS.
Copyright © 2011. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21771572      PMCID: PMC3157220          DOI: 10.1016/j.ajpath.2011.05.034

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  73 in total

Review 1.  The origin and function of tumor-associated macrophages.

Authors:  A Mantovani; B Bottazzi; F Colotta; S Sozzani; L Ruco
Journal:  Immunol Today       Date:  1992-07

2.  Tumor cell plasticity in Ewing sarcoma, an alternative circulatory system stimulated by hypoxia.

Authors:  Daisy W J van der Schaft; Femke Hillen; Patrick Pauwels; Dawn A Kirschmann; Karolien Castermans; Mirjam G A Oude Egbrink; Maxine G B Tran; Rafael Sciot; Esther Hauben; Pancras C W Hogendoorn; Olivier Delattre; Patrick H Maxwell; Mary J C Hendrix; Arjan W Griffioen
Journal:  Cancer Res       Date:  2005-12-15       Impact factor: 12.701

3.  Expression of cellular FLICE inhibitory protein, caspase-8, and protease inhibitor-9 in Ewing sarcoma and implications for susceptibility to cytotoxic pathways.

Authors:  Alfons S K de Hooge; Dagmar Berghuis; Susy Justo Santos; Esther Mooiman; Salvatore Romeo; J Alain Kummer; R Maarten Egeler; Maarten J D van Tol; Cornelis J M Melief; Pancras C W Hogendoorn; Arjan C Lankester
Journal:  Clin Cancer Res       Date:  2007-01-01       Impact factor: 12.531

4.  Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression.

Authors:  S Shimura; G Yang; S Ebara; T M Wheeler; A Frolov; T C Thompson
Journal:  Cancer Res       Date:  2000-10-15       Impact factor: 12.701

5.  Pro-inflammatory chemokine-chemokine receptor interactions within the Ewing sarcoma microenvironment determine CD8(+) T-lymphocyte infiltration and affect tumour progression.

Authors:  Dagmar Berghuis; Susy J Santos; Hans J Baelde; Antonie Hm Taminiau; R Maarten Egeler; Marco W Schilham; Pancras Cw Hogendoorn; Arjan C Lankester
Journal:  J Pathol       Date:  2010-12-10       Impact factor: 7.996

6.  CCR1 acts downstream of NFAT2 in osteoclastogenesis and enhances cell migration.

Authors:  Norihiro Ishida; Koji Hayashi; Asuka Hattori; Keiichiro Yogo; Toru Kimura; Tatsuo Takeya
Journal:  J Bone Miner Res       Date:  2005-10-10       Impact factor: 6.741

Review 7.  Spontaneous immune responses to sporadic tumors: tumor-promoting, tumor-protective or both?

Authors:  Karin E de Visser
Journal:  Cancer Immunol Immunother       Date:  2008-03-15       Impact factor: 6.968

8.  Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.

Authors:  Paul A Meyers; Cindy L Schwartz; Mark D Krailo; John H Healey; Mark L Bernstein; Donna Betcher; William S Ferguson; Mark C Gebhardt; Allen M Goorin; Michael Harris; Eugenie Kleinerman; Michael P Link; Helen Nadel; Michael Nieder; Gene P Siegal; Michael A Weiner; Robert J Wells; Richard B Womer; Holcombe E Grier
Journal:  J Clin Oncol       Date:  2008-02-01       Impact factor: 44.544

9.  Cloning and sequencing of the cDNA for human monocyte chemotactic and activating factor (MCAF).

Authors:  Y Furutani; H Nomura; M Notake; Y Oyamada; T Fukui; M Yamada; C G Larsen; J J Oppenheim; K Matsushima
Journal:  Biochem Biophys Res Commun       Date:  1989-02-28       Impact factor: 3.575

10.  Monocyte chemoattractant protein 1 and CD40 ligation have a synergistic effect on vascular endothelial growth factor production through cyclooxygenase 2 upregulation in gastric cancer.

Authors:  Seiji Futagami; Atsushi Tatsuguchi; Tetsuro Hiratsuka; Tomotaka Shindo; Akane Horie; Tatsuhiko Hamamoto; Nobue Ueki; Masafumi Kusunoki; Kazumasa Miyake; Katya Gudis; Taku Tsukui; Choitsu Sakamoto
Journal:  J Gastroenterol       Date:  2008-03-29       Impact factor: 7.527

View more
  59 in total

1.  Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes.

Authors:  Yanping Ding; Nan Song; Yongzhang Luo
Journal:  Cancer Microenviron       Date:  2012-04-20

Review 2.  [Tumor-associated macrophages: Function and differentiation].

Authors:  G Niedobitek; M H Barros; J H Dreyer; F Hauck; D Al-Sheikhyaqoob
Journal:  Pathologe       Date:  2015-09       Impact factor: 1.011

3.  Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer: a role for targeting the CCL2/CCR2 axis.

Authors:  Dominic E Sanford; Brian A Belt; Roheena Z Panni; Allese Mayer; Anjali D Deshpande; Danielle Carpenter; Jonathan B Mitchem; Stacey M Plambeck-Suess; Lori A Worley; Brian D Goetz; Andrea Wang-Gillam; Timothy J Eberlein; David G Denardo; Simon Peter Goedegebuure; David C Linehan
Journal:  Clin Cancer Res       Date:  2013-05-07       Impact factor: 12.531

Review 4.  The Elusive Role of Placental Macrophages: The Hofbauer Cell.

Authors:  Michael Z Zulu; Fernando O Martinez; Siamon Gordon; Clive M Gray
Journal:  J Innate Immun       Date:  2019-04-10       Impact factor: 7.349

Review 5.  The inextricable axis of targeted diagnostic imaging and therapy: An immunological natural history approach.

Authors:  Frederick O Cope; Bonnie Abbruzzese; James Sanders; Wendy Metz; Kristyn Sturms; David Ralph; Michael Blue; Jane Zhang; Paige Bracci; Wiam Bshara; Spencer Behr; Toby Maurer; Kenneth Williams; Joshua Walker; Allison Beverly; Brooke Blay; Anirudh Damughatla; Mark Larsen; Courtney Mountain; Erin Neylon; Kaeli Parcel; Kapil Raghuraman; Kevin Ricks; Lucas Rose; Akhilesh Sivakumar; Nicholas Streck; Bryan Wang; Christopher Wasco; Larry S Schlesinger; Abul Azad; Murugesan V S Rajaram; Wael Jarjour; Nicholas Young; Thomas Rosol; Amifred Williams; Michael McGrath
Journal:  Nucl Med Biol       Date:  2015-12-03       Impact factor: 2.408

6.  Transgenic antigen-specific, HLA-A*02:01-allo-restricted cytotoxic T cells recognize tumor-associated target antigen STEAP1 with high specificity.

Authors:  David Schirmer; Thomas G P Grünewald; Richard Klar; Oxana Schmidt; Dirk Wohlleber; Rebeca Alba Rubío; Wolfgang Uckert; Uwe Thiel; Felix Bohne; Dirk H Busch; Angela M Krackhardt; Stefan Burdach; Günther H S Richter
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

Review 7.  Macrophages and therapeutic resistance in cancer.

Authors:  Brian Ruffell; Lisa M Coussens
Journal:  Cancer Cell       Date:  2015-04-06       Impact factor: 31.743

8.  Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice.

Authors:  Cheng-Hua Zhou; Ya-Ya Wan; Xiang-Hua Chu; Zheng Song; Shu-Hua Xing; Yu-Qing Wu; Xiao-Xing Yin
Journal:  Oncol Lett       Date:  2012-09-21       Impact factor: 2.967

9.  Prognostic profiling of the immune cell microenvironment in Ewing´s Sarcoma Family of Tumors.

Authors:  David Stahl; Andrew J Gentles; Ralf Thiele; Ines Gütgemann
Journal:  Oncoimmunology       Date:  2019-10-13       Impact factor: 8.110

10.  Magnetic Resonance Imaging of Tumor-Associated Macrophages: Clinical Translation.

Authors:  Maryam Aghighi; Ashok J Theruvath; Anuj Pareek; Laura L Pisani; Raphael Alford; Anne M Muehe; Tarsheen K Sethi; Samantha J Holdsworth; Florette K Hazard; Dita Gratzinger; Sandra Luna-Fineman; Ranjana Advani; Sheri L Spunt; Heike E Daldrup-Link
Journal:  Clin Cancer Res       Date:  2018-05-15       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.